Study Stopped
Duplicative data/insufficient enrollment
ProChondrix® CR Articular Cartilage Restoration Evaluation (PACE) Registry
1 other identifier
observational
48
1 country
5
Brief Summary
The primary objective of this registry is to obtain long-term outcomes on ProChondrix CR in cartilage repair procedures of the knee, ankle, foot and hip.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2020
Typical duration for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 6, 2020
CompletedFirst Submitted
Initial submission to the registry
March 6, 2020
CompletedFirst Posted
Study publicly available on registry
March 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 14, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 14, 2023
CompletedNovember 21, 2025
November 1, 2025
3.7 years
March 6, 2020
November 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Long-Term Outcomes of ProChondrix CR
Obtain long-term results on patients who have undergone an articular cartilage repair procedure using ProChondrix CR, as assessed by patient reported outcomes.
10 Years Post-Operative
Study Arms (4)
Articular Cartilage Defect of the Knee
Patients, who undergo an articular cartilage repair of the knee using ProChondrix CR.
Articular Cartilage Defect of the Ankle
Patients, who undergo an articular cartilage repair of the ankle using ProChondrix CR.
Articular Cartilage Defect of the Foot
Patients, who undergo an articular cartilage repair of the foot using ProChondrix CR.
Articular Cartilage Defect of the Hip
Patients, who undergo an articular cartilage repair of the hip using ProChondrix CR.
Interventions
Patient reported outcomes will be collected on patients who have had a cartilage repair procedure using ProChondrix CR in the knee, hip, foot or ankle.
Eligibility Criteria
Patients, who diagnosed by their treating physician, have a cartilage defect in the knee, ankle, foot or hip that requires surgical intervention utilizing ProChondrix CR.
You may qualify if:
- Diagnosed by physician to have a cartilage defect in the knee, ankle, foot or hip that requires surgical intervention;
- Will be having, or has had, a cartilage repair procedure using ProChondrix CR;
- Has the ability to understand the requirements of the registry, to provide written informed consent and to comply with the registry protocol;
You may not qualify if:
- Is a ward of the state, prisoner, or transient.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AlloSourcelead
Study Sites (5)
University of Southern Alabama
Mobile, Alabama, 36604, United States
Rocky Mountain Foot and Ankle Center
Wheat Ridge, Colorado, 80033, United States
CAO Research Foundation
Washington D.C., District of Columbia, 20037, United States
University of Kentucky Research Foundation
Lexington, Kentucky, 40506, United States
Beacon Orthopaedics & Sports Medicine
Cincinnati, Ohio, 45247, United States
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 10 Years
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2020
First Posted
March 10, 2020
Study Start
January 6, 2020
Primary Completion
September 14, 2023
Study Completion
September 14, 2023
Last Updated
November 21, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share